Found 4 matching trials
Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors
PHASE1The purpose of this study is to evaluate the safety and tolerability of XL8...
Location
Hospital of the University of Pennsylvania Abramson Cancer Center
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
PHASE1This phase Ib trial studies the side effects and best dose of Hsp90 inhibit...
Location
Emory University Hospital Midtown
XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma
PHASE1The main purpose of this study is to determine the maximum tolerated dose (...
Status
Active Not Recruiting
Location
H. Lee Moffitt Cancer Center and Research Institute
Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma
PHASE1This is a multi-cohort, dose-escalation study of XL888 with a fixed dose of...
Location
H. Lee Moffitt Cancer Center and Research Institute